Tag: United States Oil Fund LP

  • Unusal Volume: Glu Mobile (NASDAQ:GLUU), United States Oil Fund LP (ETF) (NYSEARCA: USO), Lumber Liquidators Holdings Inc (NYSE:LL), TherapeuticsMD Inc (NYSEMKT:TXMD)

    Glu Mobile Inc. (NASDAQ:GLUU) announced the availability of Hercules: The Official Game on the App Store and Google Play. In partnership with MGM Interactive Inc. (MGM), a subsidiary of Metro-Goldwyn-Mayer Inc., Glu has developed the official free-to-play mobile game in conjunction with the new “Hercules” feature film scheduled for U.S. theatrical release from Paramount Pictures and Metro-Goldwyn-Mayer Pictures on July 25, 2014. Glu Mobile Inc. (NASDAQ:GLUU) net profit margin is -11.40% and weekly performance is 10.75%. On last trading day company shares ended up $5.46. Analysts mean target price for the company is $5.96. Glu Mobile Inc. (NASDAQ:GLUU) distance from 50-day simple moving average (SMA50) is 35.23%.

    United States Oil Fund LP (ETF) (NYSEARCA: USO) shares fell -1.28% in last trading session and ended the day on $37.69. United States Oil Fund LP (ETF) (NYSEARCA: USO) quarterly performance is 2.14%.

    Lumber Liquidators Holdings Inc (NYSE:LL) reported $0.49 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.62 by $0.13. The company had revenue of $246.30 million for the quarter, compared to the consensus estimate of $262.04 million. During the same quarter last year, the company posted $0.57 earnings per share. Lumber Liquidators Holdings’s revenue was up 6.9% compared to the same quarter last year. On average, analysts predict that Lumber Liquidators Holdings Inc will post $3.34 earnings per share for the current fiscal year. Lumber Liquidators Holdings Inc (NYSE:LL) shares moved down -8.06% in last trading session and was closed at $70.42, while trading in range of $69.65 – $77.27. Lumber Liquidators Holdings Inc (NYSE:LL) year to date (YTD) performance is -31.56%.

    On 8 JULY TherapeuticsMD Inc (NYSEMKT: TXMD) said that the current pipeline consists of drugs for the treatment of menopause-related hormone deficiencies. The company is developing remedies through hormone replacement therapies. TherapeuticsMD Inc (NYSEMKT: TXMD) ended the last trading day at $5.01. Company weekly volatility is calculated as 10.72% and price to cash ratio as 16.05. TherapeuticsMD Inc (NYSEMKT: TXMD) showed a positive weekly performance of 18.44%.